The biological activity of Mastixia arborea (MA) relates to inflammation, but the underlying mechanisms are largely unknown. We confirmed the anti-inflammatory effects of a methanol extract of MA extract on lipopolysaccharide (LPS)-stimulated RAW264.7 mouse macrophage cells and carrageenan-induced mice paw edema. The MA extract significantly inhibited nitric oxide (NO), prostaglandin E 2 (PGE 2 ), interleukin-1 (IL-1), and IL-6 production in LPS-stimulated RAW264.7 cells. In vitro expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) was suppressed by the extract. The extract attenuated acute inflammatory responses in carrageenan-induced mice paw edema. A mechanism study indicated that translocation of the NF-B (p65) subunit into the nucleus and phosphorylation of ERK and JNK were inhibited by the extract. These results indicate that the extract is an effective suppressor of the inflammatory response, blocking the phosphorylation of ERK and JNK and the translocation of NF-B in macrophages, thereby producing an anti-inflammatory effect in vivo.
The biological activity of Mastixia arborea (MA) relates to inflammation, but the underlying mechanisms are largely unknown. We confirmed the anti-inflammatory effects of a methanol extract of MA extract on lipopolysaccharide (LPS)-stimulated RAW264.7 mouse macrophage cells and carrageenan-induced mice paw edema. The MA extract significantly inhibited nitric oxide (NO), prostaglandin E 2 (PGE 2 ), interleukin-1 (IL-1), and IL-6 production in LPS-stimulated RAW264.7 cells. In vitro expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) was suppressed by the extract. The extract attenuated acute inflammatory responses in carrageenan-induced mice paw edema. A mechanism study indicated that translocation of the NF-B (p65) subunit into the nucleus and phosphorylation of ERK and JNK were inhibited by the extract. These results indicate that the extract is an effective suppressor of the inflammatory response, blocking the phosphorylation of ERK and JNK and the translocation of NF-B in macrophages, thereby producing an anti-inflammatory effect in vivo.
Key words: inflammation; Mastixia arborea; MAPK; nitric oxide; NF-B Lipopolysaccharide (LPS) is a potent activator of macrophages that produces a variety of proinflammatory mediators, including nitric oxide (NO), prostaglandins, and cytokines. 1, 2) Among these proinflammatory molecules, NO, produced by inducible nitric oxide synthase (iNOS), is associated with damage to normal cells and tissues.
3) Prostaglandin E 2 (PGE 2 ), synthesized from arachidonic acid by cyclooxygenase-2 (COX-2), also plays a major role as a mediator of the inflammatory response. 4) Similarly, interleukin-1 (IL-1) and IL-6 act significantly as proinflammatory cytokines, and are a central target in anti-inflammation therapy. 5, 6) Inhibition of NO, PGE 2 , IL-1, and IL-6 by blocking the expression of iNOS and COX-2 in macrophages is a strategy in the development of anti-inflammatory agents.
Intracellular signaling events activated by LPS regulate the phosphorylation of mitogen-activated protein kinases (MAPKs), including extracellular signal-related kinase (ERK), p38, and c-Jun N-terminal kinase (JNK), and the activation of transcription factors such as nuclear factor NF-B. 7) These signaling events lead macrophages to be transcriptionally activated and to express proinflammatory genes, including ones for cytokines, iNOS, and COX-2.
8)
Mastixia arborea C.B. Clarke (MA) is a tree that grows up to 20 m tall belonging to the Cornaceae family whose range extends from India through Southeast Asia and New Guinea to the Solomon Islands. 9) An early report indicated that MA contains a compound, loganin, in the bark, 10) but the mechanisms underlying the antiinflammatory properties of a methanol extract of MA have not been identified. In this study, we aimed to confirm the anti-inflammatory effects of a methanol extract of MA in in vitro and in vivo inflammatory models. There have been no studies focusing on the antiinflammatory activity of methanol extracts of MA in cells or animal models.
Materials and Methods
Preparation of MA extract (Mastixia arborea). Plants were collected at Quang Binh, Quang Ninh, Truong Son, Vietnam in 2008. The samples were identified by Tran The Bach of the Institute of Ecology and Biological Resources. A voucher specimen (KRIB 0019270) has been deposited in the herbarium of the Korea Research Institute of Bioscience and Biotechnology. Leaves and branches of M. arborea (67 g) were treated with MeOH and sonicated several times at room temperature for 3 d to produce an extract (4.13 g). A stock solution (20 mg/mL) of the extract was prepared in DMSO, and this was stored at À20 C before use.
Cell culture. The RAW264.7 mouse macropharge cell line was maintained under a 95% air, 5% CO 2 (v/v) atmosphere in Dulbecco's Modified Eagle's Medium (Gibco, Grand Island, NY) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Hyclone, Logan, UT) and a 1% (w/v) antibiotic-antimycotic solution (Invitrogen, Grand Island, NY).
Animal experiments. Specific pathogen-free female BALB/c mice (6 weeks old) were purchased from Koatech (Seoul, Korea), and were used after 2 weeks of quarantine and acclimatization. They were allowed sterilized tap water and standard rodent chow. All experimental procedures were carried out in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals, and were approved by the Institutional Animal Care and Use Committee of the Korea Research Institute of Bioscience and Biotechnology, and the animals were cared for in accordance with the guidelines of the National Animal Welfare Law of Korea.
11)
Cell viability. Cell viability under various concentrations of MA was determined with 3-(4,5-dimethylthiaxol-2yl)-2,5-diphenyltetrazolium bromide (MTT) (CAS#298-93-1; Amresco, Solon, OH). Briefly, an MTT solution (5 mg/mL) was added to a cell supernatant at final concentration of 0.5 mg/mL. After 4 h of incubation at 37 C, the medium was removed and DMSO was added. The optical density of formazan was measured with a microplate reader (Benchmark; BioRad Laboratories, Hercules, CA) at 570 nm. The level of formazan generated by the untreated cells was chosen as the 100% value.
Nitric oxide assay. RAW264.7 cells were plated at a density of 2:5 Â 10 5 cells/mL in 96-well plates and incubated with and without LPS (1 mg/mL) in the absence and the presence of various concentrations of MA extract for 24 h. Nitrite accumulation in the supernatants was assessed by the Griess reaction. Aliquots (100 mL) of the culture supernatants were mixed with equal volumes of Griess reagent (0.1% w/v N-(1-naphthyl)-ethylenediamine, with 1% w/v sulfanilamide in 5% v/v phosphoric acid) and incubated at room temperature for 10 min. the absorbance at 540 nm was measured with a microplate reader, and a series of known sodium nitrite concentrations served as standards. PGE 2 assay. PGE 2 levels in the supernatants were determined with a PGE 2 EIA kit (Cayman Chemical, Ann Arbor, MI) employing the manufacturer's protocol. Briefly, 50 mL doses of diluted standards and samples were pipetted into the wells of a 96-well plate precoated with goat polyclonal anti-mouse IgG. Aliquots of a PGE 2 monoclonal antibody solution and a PGE 2 acetylcholine esterase conjugate solution were added to each well, and incubation at 4 C for 18 h followed. The wells were washed 6 times with buffer containing 0.05% (v/v) Tween-20, followed by the addition of 200 mL doses of Ellman's reagent containing acetylthiocholine and 5,5
0 -dithio-bis-(2-nitrobenzoic acid). PGE 2 concentrations were measured by the absorbance at 405 nm.
Cytokine assays. The inhibitory effects of the MA extract on IL-6 and IL-1 production were measured by enzyme-linked immunosorbent assay (ELISA) of the culture supernatants. Samples were analyzed with a mouse cytokine-Quantikine kit, following the manufacturer's recommendations (Biosourse, Minneapolis, MN). The concentrations of IL-6 and IL-1 were calculated with reference to standard curves generated with the recombinant cytokines provided in the ELISA kit.
Reverse transcription (RT)-PCR analysis. Total RNA was isolated from RAW264.7 cells with TRIzol (Invitrogen, Carlsbad, CA), following the manufacturer's instructions. Briefly, the purified RNA was resuspended in diethylpyrocarbonate-treated water and its integrity was confirmed by agarose-formaldehyde electrophoresis. cDNA was synthesized from total RNA previously treated with DNA-free DNase (Ambion, Austin, TX). One mg of RNA were incubated with oligo dT 18mer (Bioneer), RNase OUT (Invitrogen), and the omniscript RT kit (Qiagen, Hilden, DE) for 60 min at 37 C, following the manufacturer's instructions. Amplification of iNOS (forward 5 0 -GGA GCG ACT TGT GGA TTG TC-3 0 , reverse 5 0 -GTG AGG GCT TGG CTG AGT GAG-3 0 ) and COX-2 (forward 5 0 -GAA GTC TTT GGT CTG GTG CCT G-3 0 , reverse 5 0 -GTC TGC TGG TTT GGA ATA GTT GC-3 0 ) was done by GeneAmp Ò PCR System 9700 (Applied Biosystems) at 94 C for 30 s, and at 56 C 30 s, and 72 C for 30 s. As internal control, -actin (forward 5 0 -AGG CTG TGC TGT CCC TGT ATG C-3 0 , reverse 5 0 -ACC CAA GAA GGA AGG CTG GAA A-3 0 ) was amplified routinely. The amplified products were resolved in agarose gel at a 1.2% (w/v), stained with Red Safe (Intron Biotechnology, Daejon, Korea), and photographed under ultraviolet light.
Western blot analysis. Cells were lysed in 100 mL of lysis buffer containing protease inhibitors (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% v/v NP-40, 0.1% w/v SDS, 1 mM EGTA, 100 mg/mL of PMSF, 10 mg/mL of pepstatin A, and 100 mM Na 3 VO 3 ). The cell lysate were centrifuged at 14,000 rpm at 4 C for 20 min, and the protein concentrations in supernatants were determined with Bradford reagent (Bio-Rad, Hercules, CA). Twenty mg of protein was loaded into each well of an SDS-polyacrylamide gel prior to electrophoresis at 100 V for 90 min, and the separated proteins were transferred to PVDF membranes (Amersham Biosciences, Piscataway, NJ). The membranes were blocked with 5% (w/v) nonfat dry milk dissolved in TBST buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% v/v Tween-20) overnight at 4 C and then incubated with primary antibodies that recognized iNOS (1:1,000, Enzo, Farmingdale, NY), COX-2 (1:1,000, Santa Cruz Biochemicals, Santa Cruz, CA), -actin (1:2,000, Abcam, Cambridge, UK), poly (ADP-ribose) polymerase (PARP), Nuclear-factor-B subunit 65 (NF-B p65), extracellular signal-regulated protein kinase (ERK)2, p38 mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK)1/3 (1:1,000, Santa Cruz Biochemicals, Santa Cruz, CA), phospho-forms of p38 MAPK and JNK1/2 (1:1000, Enzo, Farmingdale, NY), and phosphoforms of IB-, ERK, or total IB-(1:1,000, Cell Signaling Technology, Boston, MA). Immunoreactive bands were visualized with ECL reagent (Amersham Pharmacia Biotech, Uppsala, Sweden) in RAS-4000 mini (Fujifilm, Tokyo). Densitometry band values were determined with image J image analysis software (version 1.43, National Institutes of Health), and analyzed statistically.
Immunofluorescence. RAW264.7 cells were cultured on Permanox plastic chamber slides (Nunc, Rochester, NY) and fixed in ethanol at 4 C over 30 min. The slides were washed 3 times with PBS and blocked with 3% (w/v) BSA in PBS for a further 30 min. Then they were incubated for 24 h at 4 C with anti-iNOS, anti-COX-2 (rabbit polyclonal IgG, 1:200 dilution, Santa Cruz Biotechnology), and anti-NF-B p65 subunit (rabbit polyclonal IgG, 1:500 dilution, Assay Designs, Ann Arbor, MI) antibodies. After washing to remove excess primary antibody, the slides were further incubated with anti-rabbit Alexa fluor 488-conjugated or anti-rabbit Texas Red conjugated secondary antibody (Santa Cruz Biotechnology) for 2 h at room temperature, washed with PBS, and mounted with ProLong Gold Antifade reagent containing 4 0 ,6-diamidino-2-phenylindole (DAPI) (Invitrogen) for 5 min, prior to localization and quantification of nuclei. Subsequently, the slides were coverslipped and visualized by confocal laser scanning microscopy (LSM510; Carl Zeiss, Oberkochen, Germany). All samples were photographed under the same exposure conditions.
Carrageenan-induced mouse-paw edema. Carrageenan-induced paw inflammation was achieved by a method described previously. 12) Female Balb/c mice (body weight 20 g) were selected randomly and divided into groups of five to six animals. MA was dissolved in PBS and administered at doses of 40 and 80 mg/kg. The other groups were injected with the reference drug (indomethacin, 5 mg/kg, per oral) or the control (PBS). Thirty min later, edema was induced by injection of 20 mL of 1% v/v carrageenan solution in PBS into an animal's left hind paw. Measurements of the paw volume were done by caliper immediately prior to the carrageenan injection and after 4 h. Paw thickness was determined as the difference between the final and the initial thickness.
Statistics. For statistical analysis, values were expressed as means AE SEM. Statistical significance was determined by two-tailed Student's t test for independent means. p values of less than 0.05 were considered statistically significant.
Results
Effects of MA extract on NO production and iNOS activity in LPS-stimulated RAW264.7 cells iNOS is a key enzyme in the pathophysiological process of inflammation and the induction of NO. MA inhibited NO production (Fig. 1A) by inhibiting expression of the iNOS protein (Fig. 1B and D) and mRNA (Fig. 1C) . Western blot and immunofluorescence analyses indicated that LPS treatment significantly increased expression of the iNOS protein. Pretreatment of the cells with MA attenuated the LPS-induced increases in iNOS protein expression in a dose-dependent manner. RT-PCR analysis indicated that the expression of iNOS mRNA was augmented markedly in the presence of LPS alone. This suggests that the MA extract inhibited NO production and suppressed iNOS gene expression in LPS-stimulated RAW264.7 cells.
Effects of MA on PGE 2 and COX-2 production in LPS-stimulated RAW264.7 cells
Next we examined the effects of MA on PGE 2 release and COX-2 levels. Cells were stimulated with LPS and the amounts of PGE 2 released and COX-2 level were assessed with a PGE 2 ELISA kit and Western blotting. As shown in Fig. 2 , LPS increased the PGE 2 ( Fig. 2A) and COX-2 levels ( Fig. 2B and C ), but these changes were attenuated significantly by the MA extract, in a dose-dependent manner. These results suggest that MA extract can inhibit LPS-induced PGE 2 release and COX-2 production in RAW264.7 cells.
Effects of the MA extract on IL-1 and IL-6 release in LPS-stimulated RAW264.7 cells
Cytokines are produced during the inflammatory process and cytokine levels are indicative of inflammatory progression. To determine whether MA extract would affect the release of cytokines in LPS-stimulated RAW264.7 cells, we used an IL-1 and IL-6 sensitive Quantikine kit (BioSource International, Camarillo, CA). As shown in Fig. 3 , incubation of RAW264.7 cells with LPS for 24 h increased the levels of IL-1 (Fig. 3A ) and IL-6 ( , and 30 mg/mL) for 1 h, and then stimulated with LPS (1 mg/mL). Culture medium was collected at 24 h, and NO concentrations were measured by the Griess reaction. RAW264.7 cells were pretreated with MA extract for 1 h and stimulated with LPS for 6 h or 24 h. Total RNA and protein were isolated, and iNOS protein (B) and mRNA (C) were measured. -Actin expression was used as internal control in RT-PCR and Western blotting. Immunocytochemistry analysis of iNOS expression was done. After fixation, cells were stained green. Nuclei were visualized using DAPI (blue), and observed at a magnification of Â400. Control, untreated cells; LPS, LPS only (1 mg/mL); MA, MA extract (30 mg/mL) and LPS. Three independent experiments were done, and data are presented as means AE SEM.
# p < 0:05, Ã p < 0:05, ÃÃ p < 0:01, and ÃÃÃ p < 0:001 compared to control ( # ) and to cells treated with LPS alone ( Ã ). MA extract blocked increases in the cytokine level, but did not influence the cell viability of the RAW264.7 cells (Fig. 3C) .
Effects of MA on NF-B translocation and phosphorylation of ERK and JNK in LPS-stimulated RAW264.7 cells
We examined the effects of the MA extract on LPSinduced NF-B and MAPK activation. NF-B induces both iNOS and COX-2, and is translocated into the nucleus by phosphorylation of IB and subsequent degradation of IB subunit. Treatment of RAW264.7 cells with MA for 1 h markedly inhibited LPS-induced increase, in the nuclear levels of NF-B (Fig. 4A) . This suggests that MA prevents inflammatory responses such as iNOS and COX-2 expression by blocking the translocation of NF-B into the nucleus. We also examined the effects of MA extract on LPS-stimulated phosphorylation of ERK, JNK, and p38 MAPK. Cells were treated with LPS (1 mg/mL) for 5-30 min, and Western blotting was used to detect all MAPK phosphorylation. The MA extract suppressed LPS-induced phosphorylation of ERK and JNK in a dose-dependent manner (Fig. 4B) .
Effects of the MA extract on carrageenan-induced paw edema
To determine the inhibitory effects of MA on acute inflammation in vivo, we used the carrageenan-induced paw edema model. 12) Paw edema formation appeared at 1 h after exposure to carrageenan. Administration of the MA extract (40 or 80 mg/kg over 4 h) significantly reduced the increase in paw thickness induced by carrageenan. Indomethacin (5 mg/kg), an anti-inflammatory agent inhibiting prostaglandin (PG) synthesis in vivo and in vitro, was used as positive control. Figure  shows the effect of the MA extract at 4 h after exposure to carrageenan, corresponding to its maximum activity.
Discussion
Inflammation is a process regulated by a variety of immune cells and effector molecules. NO, PGE 2 , and proinflammatory cytokines are important mediators of macrophage-mediated inflammation. 13, 14) In the present study, we evaluated the anti-inflammatory effects of an MA extract both in vivo and in vitro. Carrageenan-induced paw edema is an established method of studying inflammatory states and screening for the anti-inflammatory activity of experimental compounds in animal models. A reduction of paw swelling is a good indicator of the protective action of an antiinflammatory agent. 12) As shown in Fig. 5 , MA (40 or 80 mg/kg) inhibited the formation of paw edema at 4 h after treatment. In an in vitro study, we examined the potential anti-inflammatory effects of MA by measuring LPS-induced changes in the levels of iNOS, COX-2, NO, and PGE 2 and the production of cytokines such as IL-1 and IL-6 in RAW264.7 macrophage cells. During the inflammatory process, macrophages participate in inflammatory responses by producing inflammatory cytokines IL-1 and IL-6 and other inflammatory mediators, such as NO and PGE 2 , which recruit additional immune cells to the site of infection or tissue injury. 13) As shown in Fig. 3A and B, the MA extract reduced the production of proinflammatory cytokines IL-1 and IL-6 dose dependently without cytotoxicity (Fig. 3C) . iNOS activates its effector molecule NO, a free radical synthesized from L-arginine that causes cellular damage in inflammatory sites. 15) Like iNOS, COX-2 is a key enzyme catalyzing the production of PGE 2 from arachidonic acid, which induces fever in inflammatory sites.
16) The MA extract suppressed iNOS and COX-2 expression at both the mRNA and the protein level, as well as NO and PGE 2 levels (Figs. 1  and 2 ), suggesting that it can inhibit inflammation.
LPS activates diverse intracellular signals, including the MAPK family and the NF-B signal pathway in RAW264.7 macrophages. 17) In LPS-stimulated RAW264.7 macrophage cells, the MA extract inhibited iNOS and COX-2 expression by downregulating NF-B translocation to the nucleus (Fig. 4A ) and the phosphorylation of MAPKs, including ERK and JNK (Fig. 4B) .
We used two approaches to show the effects of MA: a mouse model of carrageenan-induced inflammation, and RAW264.7 macrophage cells induced by LPS. The MA extract attenuated the paw swelling induced by carrageenan and suppressed the activation of inflammatory pathways in macrophages by preventing the induction of iNOS and COX-2 expression, by attenuating NO and PGE 2 production by inhibiting the translocation of NF-B into the nucleus, and by reducing the phosphorylation of ERK and JNK. To date Mastixia have been reported only for loganin and loganic acid. 10, 18) The iridoid compound especially loganin inhibited COX-2 enzyme activities, TNF-, and NO production in vivo 19) and in vitro. 20) Firstly we identified a biological effect of methanol extract of MA, and it is possible if extract inhibits inflammatory disease due to constituents including loganin.
